ArticleNature communications2021

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade.

Cecile Geuijen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.